Computer-Aided Detection Market Size, Share & Growth Graph by 2034

Table Of Content

Executive Summary

Research Scope & Segmentation

Research Objectives
Limitations & Assumptions
Market Scope & Segmentation
Currency & Pricing Considered

Market Opportunity Assessment

Emerging Regions / Countries
Emerging Companies
Emerging Applications / End Use

Market Trends

Drivers
Market Warning Factors
Latest Macro Economic Indicators
Geopolitical Impact
Technology Factors

Market Assessment

Porters Five Forces Analysis
Value Chain Analysis

Regulatory Framework

North America
Europe
APAC
Middle East and Africa
LATAM

ESG Trends

Global Computer-Aided Detection Market Size Analysis

Global Computer-Aided Detection Market Introduction
By Technology
1. Introduction
  1. Technology By Value
2. Deep Learning-Based
  1. By Value
3. Machine Learning-Based
  1. By Value
4. Traditional CAD Systems,
  1. By Value
5. Hybrid Models
  1. By Value
6. Others
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Tuberculosis
  1. By Value
3. Breast cancer
  1. By Value
4. Lung cancer
  1. By Value
5. Colon/rectal cancer
  1. By Value
6. Prostate cancer
  1. By Value
7. Liver cancer
  1. By Value
8. Bone cancer
  1. By Value
9. Others (Neurological/musculoskeletal/cardiovascular Indications)
  1. By Value
By Indication
1. Introduction
  1. Indication By Value
2. X-ray imaging
  1. By Value
3. Computed tomography
  1. By Value
4. Ultrasound imaging
  1. By Value
5. Magnetic resonance imaging
  1. By Value
6. Nuclear medicine imaging
  1. By Value
7. Others
  1. By Value

North America Market Analysis

Introduction
By Technology
1. Introduction
  1. Technology By Value
2. Deep Learning-Based
  1. By Value
3. Machine Learning-Based
  1. By Value
4. Traditional CAD Systems,
  1. By Value
5. Hybrid Models
  1. By Value
6. Others
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Tuberculosis
  1. By Value
3. Breast cancer
  1. By Value
4. Lung cancer
  1. By Value
5. Colon/rectal cancer
  1. By Value
6. Prostate cancer
  1. By Value
7. Liver cancer
  1. By Value
8. Bone cancer
  1. By Value
9. Others (Neurological/musculoskeletal/cardiovascular Indications)
  1. By Value
By Indication
1. Introduction
  1. Indication By Value
2. X-ray imaging
  1. By Value
3. Computed tomography
  1. By Value
4. Ultrasound imaging
  1. By Value
5. Magnetic resonance imaging
  1. By Value
6. Nuclear medicine imaging
  1. By Value
7. Others
  1. By Value
U.S.
1. By Technology
  1. Introduction
    1. Technology By Value
  2. Deep Learning-Based
    1. By Value
  3. Machine Learning-Based
    1. By Value
  4. Traditional CAD Systems,
    1. By Value
  5. Hybrid Models
    1. By Value
  6. Others
    1. By Value
2. By Application
  1. Introduction
    1. Application By Value
  2. Tuberculosis
    1. By Value
  3. Breast cancer
    1. By Value
  4. Lung cancer
    1. By Value
  5. Colon/rectal cancer
    1. By Value
  6. Prostate cancer
    1. By Value
  7. Liver cancer
    1. By Value
  8. Bone cancer
    1. By Value
  9. Others (Neurological/musculoskeletal/cardiovascular Indications)
    1. By Value
3. By Indication
  1. Introduction
    1. Indication By Value
  2. X-ray imaging
    1. By Value
  3. Computed tomography
    1. By Value
  4. Ultrasound imaging
    1. By Value
  5. Magnetic resonance imaging
    1. By Value
  6. Nuclear medicine imaging
    1. By Value
  7. Others
    1. By Value
Canada

Europe Market Analysis

Introduction
By Technology
1. Introduction
  1. Technology By Value
2. Deep Learning-Based
  1. By Value
3. Machine Learning-Based
  1. By Value
4. Traditional CAD Systems,
  1. By Value
5. Hybrid Models
  1. By Value
6. Others
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Tuberculosis
  1. By Value
3. Breast cancer
  1. By Value
4. Lung cancer
  1. By Value
5. Colon/rectal cancer
  1. By Value
6. Prostate cancer
  1. By Value
7. Liver cancer
  1. By Value
8. Bone cancer
  1. By Value
9. Others (Neurological/musculoskeletal/cardiovascular Indications)
  1. By Value
By Indication
1. Introduction
  1. Indication By Value
2. X-ray imaging
  1. By Value
3. Computed tomography
  1. By Value
4. Ultrasound imaging
  1. By Value
5. Magnetic resonance imaging
  1. By Value
6. Nuclear medicine imaging
  1. By Value
7. Others
  1. By Value
U.K.
1. By Technology
  1. Introduction
    1. Technology By Value
  2. Deep Learning-Based
    1. By Value
  3. Machine Learning-Based
    1. By Value
  4. Traditional CAD Systems,
    1. By Value
  5. Hybrid Models
    1. By Value
  6. Others
    1. By Value
2. By Application
  1. Introduction
    1. Application By Value
  2. Tuberculosis
    1. By Value
  3. Breast cancer
    1. By Value
  4. Lung cancer
    1. By Value
  5. Colon/rectal cancer
    1. By Value
  6. Prostate cancer
    1. By Value
  7. Liver cancer
    1. By Value
  8. Bone cancer
    1. By Value
  9. Others (Neurological/musculoskeletal/cardiovascular Indications)
    1. By Value
3. By Indication
  1. Introduction
    1. Indication By Value
  2. X-ray imaging
    1. By Value
  3. Computed tomography
    1. By Value
  4. Ultrasound imaging
    1. By Value
  5. Magnetic resonance imaging
    1. By Value
  6. Nuclear medicine imaging
    1. By Value
  7. Others
    1. By Value
Germany
France
Spain
Italy
Russia
Nordic
Benelux
Rest of Europe

APAC Market Analysis

Introduction
By Technology
1. Introduction
  1. Technology By Value
2. Deep Learning-Based
  1. By Value
3. Machine Learning-Based
  1. By Value
4. Traditional CAD Systems,
  1. By Value
5. Hybrid Models
  1. By Value
6. Others
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Tuberculosis
  1. By Value
3. Breast cancer
  1. By Value
4. Lung cancer
  1. By Value
5. Colon/rectal cancer
  1. By Value
6. Prostate cancer
  1. By Value
7. Liver cancer
  1. By Value
8. Bone cancer
  1. By Value
9. Others (Neurological/musculoskeletal/cardiovascular Indications)
  1. By Value
By Indication
1. Introduction
  1. Indication By Value
2. X-ray imaging
  1. By Value
3. Computed tomography
  1. By Value
4. Ultrasound imaging
  1. By Value
5. Magnetic resonance imaging
  1. By Value
6. Nuclear medicine imaging
  1. By Value
7. Others
  1. By Value
China
1. By Technology
  1. Introduction
    1. Technology By Value
  2. Deep Learning-Based
    1. By Value
  3. Machine Learning-Based
    1. By Value
  4. Traditional CAD Systems,
    1. By Value
  5. Hybrid Models
    1. By Value
  6. Others
    1. By Value
2. By Application
  1. Introduction
    1. Application By Value
  2. Tuberculosis
    1. By Value
  3. Breast cancer
    1. By Value
  4. Lung cancer
    1. By Value
  5. Colon/rectal cancer
    1. By Value
  6. Prostate cancer
    1. By Value
  7. Liver cancer
    1. By Value
  8. Bone cancer
    1. By Value
  9. Others (Neurological/musculoskeletal/cardiovascular Indications)
    1. By Value
3. By Indication
  1. Introduction
    1. Indication By Value
  2. X-ray imaging
    1. By Value
  3. Computed tomography
    1. By Value
  4. Ultrasound imaging
    1. By Value
  5. Magnetic resonance imaging
    1. By Value
  6. Nuclear medicine imaging
    1. By Value
  7. Others
    1. By Value
Korea
Japan
India
Australia
Taiwan
South East Asia
Rest of Asia-Pacific

Middle East and Africa Market Analysis

Introduction
By Technology
1. Introduction
  1. Technology By Value
2. Deep Learning-Based
  1. By Value
3. Machine Learning-Based
  1. By Value
4. Traditional CAD Systems,
  1. By Value
5. Hybrid Models
  1. By Value
6. Others
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Tuberculosis
  1. By Value
3. Breast cancer
  1. By Value
4. Lung cancer
  1. By Value
5. Colon/rectal cancer
  1. By Value
6. Prostate cancer
  1. By Value
7. Liver cancer
  1. By Value
8. Bone cancer
  1. By Value
9. Others (Neurological/musculoskeletal/cardiovascular Indications)
  1. By Value
By Indication
1. Introduction
  1. Indication By Value
2. X-ray imaging
  1. By Value
3. Computed tomography
  1. By Value
4. Ultrasound imaging
  1. By Value
5. Magnetic resonance imaging
  1. By Value
6. Nuclear medicine imaging
  1. By Value
7. Others
  1. By Value
UAE
1. By Technology
  1. Introduction
    1. Technology By Value
  2. Deep Learning-Based
    1. By Value
  3. Machine Learning-Based
    1. By Value
  4. Traditional CAD Systems,
    1. By Value
  5. Hybrid Models
    1. By Value
  6. Others
    1. By Value
2. By Application
  1. Introduction
    1. Application By Value
  2. Tuberculosis
    1. By Value
  3. Breast cancer
    1. By Value
  4. Lung cancer
    1. By Value
  5. Colon/rectal cancer
    1. By Value
  6. Prostate cancer
    1. By Value
  7. Liver cancer
    1. By Value
  8. Bone cancer
    1. By Value
  9. Others (Neurological/musculoskeletal/cardiovascular Indications)
    1. By Value
3. By Indication
  1. Introduction
    1. Indication By Value
  2. X-ray imaging
    1. By Value
  3. Computed tomography
    1. By Value
  4. Ultrasound imaging
    1. By Value
  5. Magnetic resonance imaging
    1. By Value
  6. Nuclear medicine imaging
    1. By Value
  7. Others
    1. By Value
Turkey
Saudi Arabia
South Africa
Egypt
Nigeria
Rest of MEA

LATAM Market Analysis

Introduction
By Technology
1. Introduction
  1. Technology By Value
2. Deep Learning-Based
  1. By Value
3. Machine Learning-Based
  1. By Value
4. Traditional CAD Systems,
  1. By Value
5. Hybrid Models
  1. By Value
6. Others
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Tuberculosis
  1. By Value
3. Breast cancer
  1. By Value
4. Lung cancer
  1. By Value
5. Colon/rectal cancer
  1. By Value
6. Prostate cancer
  1. By Value
7. Liver cancer
  1. By Value
8. Bone cancer
  1. By Value
9. Others (Neurological/musculoskeletal/cardiovascular Indications)
  1. By Value
By Indication
1. Introduction
  1. Indication By Value
2. X-ray imaging
  1. By Value
3. Computed tomography
  1. By Value
4. Ultrasound imaging
  1. By Value
5. Magnetic resonance imaging
  1. By Value
6. Nuclear medicine imaging
  1. By Value
7. Others
  1. By Value
Brazil
1. By Technology
  1. Introduction
    1. Technology By Value
  2. Deep Learning-Based
    1. By Value
  3. Machine Learning-Based
    1. By Value
  4. Traditional CAD Systems,
    1. By Value
  5. Hybrid Models
    1. By Value
  6. Others
    1. By Value
2. By Application
  1. Introduction
    1. Application By Value
  2. Tuberculosis
    1. By Value
  3. Breast cancer
    1. By Value
  4. Lung cancer
    1. By Value
  5. Colon/rectal cancer
    1. By Value
  6. Prostate cancer
    1. By Value
  7. Liver cancer
    1. By Value
  8. Bone cancer
    1. By Value
  9. Others (Neurological/musculoskeletal/cardiovascular Indications)
    1. By Value
3. By Indication
  1. Introduction
    1. Indication By Value
  2. X-ray imaging
    1. By Value
  3. Computed tomography
    1. By Value
  4. Ultrasound imaging
    1. By Value
  5. Magnetic resonance imaging
    1. By Value
  6. Nuclear medicine imaging
    1. By Value
  7. Others
    1. By Value
Mexico
Argentina
Chile
Colombia
Rest of LATAM

Competitive Landscape

Computer-Aided Detection Market Share By Players
M&A Agreements & Collaboration Analysis

Market Players Assessment

EDDA Technology, Inc.
1. Overview
2. Business Information
3. Revenue
4. ASP
5. SWOT Analysis
6. Recent Developments
Olympus Corporation
Aidoc
FUJIFILM Holdings Corporation
Hologic, Inc.
Koninklijke Philips N.V.
Siemens Healthineers AG
NANO-X IMAGING LTD.
Canon Medical Systems Corporation
GE Healthcare
Quibim
IBM
Riverain Technologies
iCAD, Inc.
Median Technologies
Hitachi, Ltd.
Shimadzu Analytical (India) Pvt. Ltd
Carestream Health
Esaote SpA
Cleerly
Planmeca
DeepHealth
AZmed
Medical Care Technologies Inc.

Research Methodology

Research Data
1. Secondary Data
  1. Major secondary sources
  2. Key data from secondary sources
2. Primary Data
  1. Key data from primary sources
  2. Breakdown of primaries
3. Secondary And Primary Research
  1. Key industry insights
Market Size Estimation
1. Bottom-Up Approach
2. Top-Down Approach
3. Market Projection
Research Assumptions
1. Assumptions
Limitations
Risk Assessment